flibanserin
Sponsors
Sprout Pharmaceuticals, Inc, San Diego Sexual Medicine, University of Chicago, Mohit Khera
Conditions
Hypoactive Sexual Desire DisorderLow LibidoSexual Dysfunctions, Psychological
Phase 2
Phase 3
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
CompletedNCT00277914
Start: 2006-01-31Updated: 2012-03-16
6-mo. Min Eff Dose of Flibanserin: 25 v 50 mg Bid v 50 mg hs v Pbo in Younger Women in NA
CompletedNCT00360243
Start: 2006-07-31End: 2008-04-30Updated: 2016-06-27
Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
CompletedNCT00360555
Start: 2006-07-31End: 2008-03-31Updated: 2016-06-27
24-week Placebo-controlled Trial of Flibanserin Once Daily in Premenopausal Women With Hypoactive Sexual Desire Disorder
CompletedNCT00360529
Start: 2006-07-31End: 2008-04-30Updated: 2016-06-27
A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
TerminatedNCT00441558
Start: 2007-02-28End: 2009-08-31Updated: 2014-06-13
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
CompletedNCT00996372
Start: 2009-10-31End: 2011-03-31Updated: 2014-06-12
Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder
CompletedNCT00996164
Start: 2009-10-31End: 2011-02-28Updated: 2014-05-19
Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women in North America
TerminatedNCT01057901
Start: 2010-01-31End: 2011-01-31Updated: 2014-06-17
A 28-week Safety Study of Flibanserin in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder
TerminatedNCT01103362
Start: 2010-04-30End: 2011-01-31Updated: 2014-05-12